ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RS vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Reliance Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RS 5 — TMO 8
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RS VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RS TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 9.60% 9.30% +0.30 RS /roic <GO>
EV/EBITDA & P/E Valuation 18.3x 30.4x -12.10 RS /valuation <GO>
Free Cash Flow Yield 2.24% 2.40% -0.16 TMO /fcf-yield <GO>
Operating Margin 7.10% 17.40% -10.30 TMO /operating-margins <GO>
Net Profit Margin 5.20% 15.10% -9.90 TMO /net-margins <GO>
Revenue Growth (YoY) 3.30% 3.90% -0.60 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 7.27 4.50 +2.77 RS /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 72.5 62.9 +9.60 RS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.89 0.94 -0.05 TMO /macro-sensitivity <GO>
Forward P/E Multiple 28.2x 36.3x -8.10 RS /forward-pe <GO>
Enterprise Scale & Market Cap $22.40B $262.22B -$239.82B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RS REV TMO REV RS GROSS % TMO GROSS % RS FCF TMO FCF
FY 2025 $14.29B $44.56B — — $502.5M $6.29B
FY 2024 $13.84B $42.88B — — $999.2M $7.27B
FY 2023 $14.81B $42.86B — — $1.01B $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RS // BETA 0.89
TMO // BETA 0.94